1004-1016.33.Blevins T, Pullman J, Malloy J, et al. DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control com- pared with exenatide twice daily in patients with type 2 diabetes. J Clin Endocrinol Metab . 2011;96:1301-1310. 34.Kennedy L, Herman WH, Strange P, Harris A. Impact of active ver- sus usual algorithmic titration of basal insulin and point-of-care ver- sus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algo-rithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care . 2006;29:1-8. 35.Meneghini L, Koenen C, Weng W, Selam JL. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes â€”results of the randomized, controlled PREDICTIVE 303 study. Diabetes Obes Metab . 2007;9:902-913. SUPPORTING INFORMATION Additional Supporting Information may be found online in the sup-